Timing Pharmaceutical Co

Timing Pharmaceutical Co EBIT per Share

The EBIT per Share of Timing Pharmaceutical Co (6659.TWO) as of Oct 12, 2026 is 0.50 TWD. In the previous year, EBIT per Share was 0.84 TWD — a change of -40.49% (lower).

EBIT per Share

0.50TWD

YoY

-40.49%

Last updated:

EBIT per Share of Timing Pharmaceutical Co is 2024 0.50 TWD. EBIT per Share of Timing Pharmaceutical Co was 2023 0.84 TWD. It decreases by -40.49% lower compared to the previous year.

The Timing Pharmaceutical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
0.66 TWD
Jan 1, 2023
0.84 TWD
Jan 1, 2024
0.50 TWD
The Timing Pharmaceutical Co EBIT per Share history
YEAREBIT per ShareYoY
0.50TWD-40.49%
0.84TWD+28.20%
0.66TWD—
Access this data via the Eulerpool API
Get Free API Key

Timing Pharmaceutical Co Stock analysis

What does Timing Pharmaceutical Co do? Timing Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Timing Pharmaceutical Co stock

EBIT per Share of Timing Pharmaceutical Co is 0.50 TWD in 2024.

EBIT per Share of Timing Pharmaceutical Co changed from 0.84 TWD to 0.50 TWD, representing a -40.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Timing Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Timing Pharmaceutical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Timing Pharmaceutical Co